← Leaderboards
Lindsey Allison George
Children'S Hosp Of Philadelphia
$1,334,602
Attributed
$1,334,602
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $637K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,334,602 · 2
By mechanism
K08$697,620 · 1
R01$636,982 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Sriram Krishnaswamy$22,716,630
- Rodney M Camire$12,955,560
- Ben J Samelson-Jones$4,366,849
- Bruce Alan Sullenger$24,141,070
- Wayne William Hancock$20,750,331
Others in their field
Other Emerging Leaders on “Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Yunda Huang · Fred Hutchinson Cancer Center$54,278,170
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kathleen Maletic Neuzil · Emory University$26,552,931
Research focus
KineticsRegulationGene TherapyIn VivoMouse ModelProteinsEndotheliumFactor ViiiaHemostatic FunctionIn VitroDissociationBiochemistryPhysiologicalCoagulation ProcessBiologyActivated Protein CFactor ViiiBlood Coagulation DisordersHemophilia AHemorrhageBypassInvestigationBiochemicalResistance
Grant awards (6)
Proteolytic Regulation of Factor VIII Before and After Activation$636,982
R01 · FY2025 · HL · contact PI
Therapeutic Applications of Factor VIIIa Inactivation in Hemophilia A$104,071
K08 · FY2023 · HL · contact PI
Therapeutic Applications of Factor VIIIa Inactivation in Hemophilia A$113,705
K08 · FY2022 · HL · contact PI
Therapeutic Applications of Factor VIIIa Inactivation in Hemophilia A$159,948
K08 · FY2021 · HL · contact PI
Therapeutic Applications of Factor VIIIa Inactivation in Hemophilia A$159,948
K08 · FY2020 · HL · contact PI
Therapeutic Applications of Factor VIIIa Inactivation in Hemophilia A$159,948
K08 · FY2019 · HL · contact PI